Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility

G. Caleb Alexander, Scott Emerson, Aaron S. Kesselheim

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish (US)
JournalJAMA - Journal of the American Medical Association
DOIs
StateAccepted/In press - 2021

ASJC Scopus subject areas

  • Medicine(all)

Cite this